Remote monitoring of heart failure therapy
Part of Heart & circulation clinical trials.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You are currently in the hospital for acute heart failure (sudden worsening) with symptoms like shortness of breath, fluid swelling, and certain blood test results.
- You have not been on the highest doses of certain heart failure medications like ACE inhibitors, ARBs, or beta-blockers before this hospital stay.
- Your vital signs (like blood pressure and heart rate) must be stable enough in the 24 hours before starting, and your potassium level must be within safe range.
- You don't have serious lung disease, recent heart surgery, or other major health conditions that would interfere.
- You don't have skin allergies or skin problems at the patch application site, and you haven't had a heart transplant or certain implanted devices.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This trial tests whether remote monitoring of heart function can help manage heart failure. It may be an option if you have symptoms like shortness of breath or fatigue (NYHA class II or higher) and are between 18 and 90 years old.
This study tests a home monitoring device and follow-up care for people recently treated for heart failure in the emergency room. It aims to help manage your condition and avoid future hospital stays.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.